DSM dairy enzyme has European patent

In 2014, DSM celebrates its 50^th year in the lactase market. Fittingly, the company has announced that its new patent application for Maxilact^? lactase has been granted in Europe. This product is free from arylsulfatase, an enzyme in lactase that causes off-flavours when converting components naturally found in milk. When Maxilact is added to dairy formulations, it eliminates off-flavours as well as extends product shelf life.

“The lactose-free dairy market continues to expand globally and we see a rapid growth in overseas exports. This requires a longer shelf life and is thereby putting extra demands on enzyme quality,” said Merel Roes, marketing manager, Maxilact.

DSM, which offers a wide range of products, including dietary supplements, was first to develop a solution for low lactose milk, ice cream, and other dairy products.